18F-FDG PET in stage IB/IIB cervical adenocarcinoma/ adenosquamous carcinoma

Hung Hsueh Chou, Hsiu Ping Chang, Chyong Huey Lai, Koon Kwan Ng, Swei Hsueh, Tzu I. Wu, Ming Yu Chen, Tzu Chen Yen, Ji Hong Hong, Ting Chang Chang

研究成果: 雜誌貢獻文章同行評審

30 引文 斯高帕斯(Scopus)


Purpose: The diagnostic and prognostic value of 18F-FDG PET in cervical adenocarcinoma/adenosquamous carcinoma (AC/ASC) is unclear. The aim of this study was to assess the value of PET in the management of cervical AC/ASC. Methods: Patients with resectable FIGO stage IB/IIB cervical AC/ASC receiving a preoperative MRI scan and a PET or PET/CT scan before radical surgery were eligible. Diagnostic efficacy was compared by receiver operating characteristic (ROC) analysis. Correlations between clinicopathological parameters and outcome and maximum standardized uptake values (SUVmax) of FDG uptake were evaluated. Results: The study group comprised 83 patients (mean age 48.3±9.7 years) Five-year overall survival was 85.5%, with a median follow-up time of 38.6 months (range 2.8-87.2 months). Pelvic lymph node (PLN) and paraaortic lymph node (PALN) metastases were seen in 32.5% and 8.4% of patients, respectively. The difference in diagnostic efficacy in identifying metastatic PALN between PET and MRI was significant (PET versus MRI, area under the curve 0.832 versus 0.607, p=0.039). SUVmax in primary tumour was correlated with LN metastasis and deep stromal invasion. Overall survival was significantly related to FIGO stage, PLN metastasis, deep cervical stromal invasion, tumour size measured by MRI, and SUVmax of the primary cervical tumour. Conclusion: PET provided significantly better diagnostic efficacy than MRI in detecting PALN metastasis. Poor prognostic factors in cervical AC/ASC were SUVmax of the primary cervical tumour >5.3, stage IIB, deep cervical stromal invasion, tumour size measured by MRI >40 mm, and PLN metastasis.

頁(從 - 到)728-735
期刊European Journal of Nuclear Medicine and Molecular Imaging
出版狀態已發佈 - 4月 2010

ASJC Scopus subject areas

  • 放射學、核子醫學和影像學


深入研究「18F-FDG PET in stage IB/IIB cervical adenocarcinoma/ adenosquamous carcinoma」主題。共同形成了獨特的指紋。